INTEGRA LIFESCIENCES HOLDINGS CORP - 8-K Filing

Integra LifeSciences reports Q3 2026 financial results with organic revenue growth and adjusted earnings guidance (Items: 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITIONOn October 21, 2026, Integra LifeSciences Holdings Corporation (the “Company”) issued a press re, 9.01 FINANCIAL STATEMENTS AND EXHIBITS(d) Exhibits99)

SEC EDGAR ·

Tickers: $IART

Read the full article at SEC EDGAR

Part of the story ALASKA AIR GROUP, INC. - 8-K Filing (3 articles)

More Regulatory news